Assignee
VISTAGEN THERAPEUTICS INC
US·6 granted patents·9 pending applications·2 citations·filing 2014–2025
Top patents by PatentIndex Score
15 records- 0185US2025161251A1Dosage forms and therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0275US9834801B2Methods for the synthesis of chiral kynurenine compoundsVISTAGEN THERAPEUTICS INC·Filed 2014·Granted Dec 5, 2017·2 cites·16 claims
- 0373US2024122887A1Therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0471US10632091B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·0 cites·6 claims
- 0570US9993450B2Dosage forms and therapeutic uses of L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·0 cites·3 claims
- 0664US9993453B2Dosage forms and therapeutic uses L-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2016·Granted Jun 12, 2018·0 cites·11 claims
- 0758US2019321317A1Therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0857US10294502B2Methods for the synthesis of chiral kynurenine compoundsVISTAGEN THERAPEUTICS INC·Filed 2017·Granted May 21, 2019·0 cites·6 claims
- 0952US2025312544A1Intranasal drug delivery systemVISTAGEN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1049US2022202756A1Genetic variants associated with response to treatment of neurological disordersVISTAGEN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1147US2025312356A1Treatment of dysmenorrheaVISTAGEN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1247US2018140568A1Therapeutic uses of l-4-chlorokynurenineVISTAGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1346US11427530B2Synthesis of 4-chlorokynurenines and intermediatesVISTAGEN THERAPEUTICS INC·Filed 2019·Granted Aug 30, 2022·0 cites·12 claims
- 1446US2023210867A1Treatment of adjustment disordersVISTAGEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1537US2016031800A1Synthesis of chiral kynurenine compounds and intermediatesVISTAGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →